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Possible mechanisms of homocysteine toxicity. Hyperhomo- tion, increases platelet aggregation, and acts on the coag-
cysteinemia is a risk factor for cardiovascular disease in the ulation cascade and fibrinolysis, directly inducing, or act-
general population. In chronic renal failure (CRF), plasma
ing in a synergistic manner with other risk factors inhomocysteine levels rise when the glomerular filtration rate
creating a prothrombotic environment. It activates coag-(GFR) is reduced 50%, and in uremia the majority of patients
are hyperhomocysteinemic. The purpose of this study was to ulation factor V, X, and XII, along with decreased activa-
review possible mechanisms of homocysteine toxicity. Homo- tion of protein C and cell-surface thrombomodulin, and
cysteine, a sulfur amino acid found in blood in micromolar con-
modulation of tissue plasminogen activator binding tocentrations, can have toxic effects through a handful of general
its endothelial receptor, annexin II.possible mechanisms. These mechanisms include oxidative stress
(through the production of reactive oxygen species), binding Proposed toxicity mechanisms are oxidation, nitrosy-
to nitric oxide, production of homocysteinylated/acylated pro- lation, homocysteinylation, and hypomethylation. It hasteins, and accumulation of its precursor, S-adenosyl-homocys-
to be stressed that the different mechanisms of homocys-teine, a potent inhibitor of transmethylation reactions. Methyl-
transferase inhibition actually occurs in CRF and in uremia, teine toxicity are not mutually exclusive.
and can have several functional consequences.
Oxidation
Thiols can auto-oxidize in the presence of transition
Hyperhomocysteinemia is a strong predictor of cardio-
metal catalysts and molecular oxygen, leading to thevascular disease (CVD) in the general population [1]. A
formation of reactive oxygen species (ROS). Homocys-clear link between homocysteine and CVD was found
teine can induce a pro-oxidant action in vitro throughin monogenic diseases called, as a whole, homocystin-
hydrogen peroxide production during metal-catalyzeduria, in which plasma homocysteine concentration in-
oxidation, and, in the presence of nitric oxide, the super-creases several-fold (400 to 500 mol/L). More recently,
oxide anion can form powerful oxidant peroxynitrite [3].mild (16mol/L) hyperhomocysteinemia has been rec-
Formation of ROS could lead to lipid peroxidation,ognized as a CVD risk factor in the general population,
which initiates an inflammatory response and is involvedand in a number of acquired conditions, such as chronic re-
nal failure (CRF), where homocysteine levels can range in establishing foam cells, a key atherosclerotic lesion
from moderate (16 to 30 mol/L) to intermediate (30 to component. Studies performed in vitro have shown both
100mol/L). In a recent study, a population of 175 chronic a pro-oxidant and an antioxidant effect of homocysteine
hemodialysis patients followed for 29 months showed on LDL oxidation. Thiols can function as anti- or pro-
an increase in mortality rates, which was higher in the oxidants, depending on the physical location (intra- or
patients with the highest homocysteine levels at baseline extracellular) of the oxidative damage occurring to lipo-
[2]. Statistical adjustment for confounders and tradi- proteins. Depending on the experimental condition,
tional and nontraditional risk factors was performed. homocysteine can both inhibit and promote LDL oxida-
tion, and it has been speculated that its concentration
MECHANISMS OF ACTION (low  pro-oxidant, high  anti-oxidant) determines
which activity will prevail [4]. However, phosphatidyl-Hyperhomocysteinemia can be toxic for the endothe-
choline hydroperoxide, a product of lipid peroxidation,lium; it enhances vascular smooth muscle cell prolifera-
and P-selectin, a cell adhesion molecule and a marker
of endothelial damage, did not change after a methionineKey words: homocysteine, uremia, mechanisms of toxicity, hypometh-
ylation. load, suggesting that effects of homocysteine on endothe-
lium are not mediated by oxidative stress mechanisms 2003 by the International Society of Nephrology
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Fig. 1. Mechanism of albumin-bound homocysteine. Homocysteine
first displaces the cysteine residue present in position 34 of albumin.
The favored reactions are as follows: the homocysteine sulfydryl group
reacts with the sulfur of the cysteine residue, forming the homocysteine-
cysteine mixed disulfide and free albumin thiolate anion. Subsequently,
albumin thiolate anion attacks the homocysteine-cysteine mixed disul-
fide on the homocysteine sulfur to form albumin-bound homocysteine
and cysteine thiolate anion [14].
[5]. Clearly, more studies are necessary to elucidate the
role of homocysteine on lipoprotein oxidation.
Homocysteine can impair endothelial cell function,
which can be monitored by the reduction in endothe-
lium-derived flow-mediated vasodilation by either a me-
thionine load in healthy individuals, or in hyperhomocys-
teinemic patients [6–7]. Because of the protective effects
exerted by administration of antioxidants such as vitamin
C and E [8], and because of cell culture studies showing
that homocysteine leads to considerable toxic effects me-
diated by ROS formation, it has been suggested that
effects of homocysteine on endothelium occur via oxida-
Fig. 2. Plasma protein homocysteinylation and thiol binding. Fifty sixtive stress.
mg of plasma proteins (0.8 mL, homocysteine concentration 5 M) of
The activity of extracellular superoxide dismutase, an normal healthy individuals were incubated (2 h at 37C) with or without
DL-homocysteine (100 M final concentration). After 120 minutes, incu-important antioxidant in vascular tissue, was measured
bation samples were subjected to microfiltration in order to separatealong with homocysteine in homocystinuric patients and
protein-bound and non-bound thiols. Thiols were evaluated in both
found to be positively associated with homocysteine lev- the retentate and diafiltrate buffer by means of HPLC. Results were
corrected for the final volumes of retentate (about 800l) and diafiltrateels. This strong relationship can be envisioned as a pro-
(about 1300 l). Panel A: retentate of sample preincubated withouttective antioxidant response to homocysteine-induced oxi-
homocysteine; Panel B: retentate of a homocysteine-treated sample;
dative damage [9]. Panel C: diafiltrate of the sample not treated with homocysteine; Panel
D: diafiltrate of the homocysteine-treated sample. Abbreviations are:Zappacosta et al [10] found that homocysteine pro-
cysteine (Cys); cysteinylglycine (CysGly); homocysteine (Hcy).duces only negligible quantities of hydrogen peroxide
(1:4000 mmol of hydrogen peroxide/mole of homocys-
teine), and only when catalyst metal ions are present.
Hydrogen peroxide was measured with a sensitive fluo- stress may generate within vascular cells, but not neces-
rometric method. According to these authors, homocys- sarily as a result of thiol oxidation [13]. In addition, per-
teine at micromolar concentrations does not act as a pro- haps folates, other B vitamins, and vitamin C and E are
oxidant but displays an antioxidant effect on cellular and protective via mechanisms independent of their homo-
chemical systems. cysteine-lowering or antioxidant effects.
Importantly, only a small fraction of homocystine (the The mechanism of homocysteine binding to plasma pro-
oxidized form of homocysteine, also termed homocys- teins is important since this amino acid is mostly trans-
teine homodimer) in blood is formed through a direct ported though circulation in this form. Despite the rather
oxidative process, and albumin-bound homocysteine high binding capacity of plasma proteins for thiols, a re-
forms primarily through formation of an albumin thio- distribution of protein-bound thiols takes place during
late anion (Fig. 1). The investigators conclude that the hyperhomocysteinemia independently from any metabolic
role of copper-catalyzed or ceruloplasmin-catalyzed au- effect. An example of the displacement of protein-bound
toxidation of homocysteine is probably a minor process cysteine operated by homocysteine is given in Fig. 2. Two
major consequences arise from increasing homocysteinein circulation [11–12]. It has been proposed that oxidative
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concentration in this in vitro system. After diafiltration Plasma proteins, incubated in the presence of homocys-
to remove free non–protein-bound thiols in the sample teine thiolactone, form spontaneously homocysteiny-
not added with homocysteine, the peak of this amino lated proteins, with complete disappearance of thiolac-
acid almost disappears from diafiltrate, confirming that tone from the medium after three hours. Consequences
most homocysteine is bound to proteins (compare Fig. 2 of protein homocysteinylation are protein damage with
A and C). In the sample incubated with homocysteine, an altered electrophoretic mobility, and loss of enzymatic
the proportion of free (non–protein-bound) homocys- activity (with protein denaturation) in several model sys-
teine increases significantly (Fig. 2 B and D). Protein- tems, such as plasma proteins, methionyl tRNA synthe-
bound homocysteine accounts for 99% and 68% of total, tase, tripsyn, lysin oxidase, etc. Normally, it is not possible
in the samples incubated without and with, homocys- to measure homocysteine thiolactone in blood, probably
teine, respectively. Results shows that protein-bound because of its high reactivity and/or low concentration.
cysteine and the dipeptide cysteine-glycine decrease in However, when there is an increase in blood homocys-
the sample incubated with homocysteine, compared to teine, a parallel increase in homocysteinylated proteins
the sample in the absence of homocysteine (Fig. 2 B can be observed. Protein homocysteinylation could be
vs. 2 A). The percentage of protein-bound cysteine and one of the principal mediators of homocysteine toxicity,
cysteine-glycine is 49% (cysteine) and 44% (cysteine- helping to determine structural and functional alter-
glycine) in the high-homocysteine sample, compared to ations at the molecular and cellular level [15].
86% (cysteine) and 81% (cysteine-glycine) in the low-
homocysteine samples, respectively. Hypomethylation
These results, obtained in a cell-free system, suggest An increase in plasma levels of homocysteine in uremic
that displacement may play a significant contribution, patients leads to a rise in the intracellular concentration
although in vivo effects due to metabolic adjustments of AdoHcy [16]. This thioether is the only homocysteine
need to be considered in a general mechanism of action. precursor and the natural inhibitor of all AdoMet-
In favor of this interpretation is the reported existence dependent transmethylation reactions. The ratio [Ado-
of disulfide interchange in human serum albumin [11] Met]/[AdoHcy] is a good indicator of the normal flow
(Fig. 1). Moreover, the situation described by our find- of methyl groups transferred from the methyl donor to
ings may cause an increased intracellular availability of methyl acceptors within the cell. The rise of AdoHcy
free homocysteine. concentration in erythrocytes of uremic patients, which
is not paralleled by a rise of AdoMet concentration, givesNitrosylation
way to a significant reduction of the [AdoMet]/[AdoHcy]Endothelial cells can detoxify homocysteine through
ratio. This causes a significant impairment of AdoMet-release of nitric oxide, with an accompanying increase
dependent membrane protein carboxyl methylation re-in Nos3 mRNA levels [3]. From the oxidation of homo-
action, catalyzed by protein carboxyl methyltransferasecysteine with nitric oxide, S-nitroso-homocysteine for-
(PCMT, EC 2.1.1.77). This ubiquitous methylation reac-mation ensues. S-nitroso-homocysteine has vasodilatory
tion is involved in the repair of molecular damage, repre-and platelet antiaggregation properties, and does not
sented by L-isoaspartyl residues, spontaneously occur-support hydrogen peroxide generation. This represents
ring in proteins through deamidation of labile asparaginea protective mechanism against the adverse effects of
residues. Several crucial transmethylation-dependenthomocysteine. The scavenging effect of homocysteine is
processes, in addition to protein repair in cells differentovercome in chronic exposure to high homocysteine,
from erythrocytes, can be affected by a reduction in theleading to a reduced production or availability of NO·,
[AdoMet]/[AdoHcy] ratio. It has been shown that anleading to unopposed oxidative injury mediated by homo-
increase in plasma homocysteine is associated with paral-cysteine and formation of peroxynitrite.
lel increases in plasma AdoHcy and lymphocyte DNAHomocysteine may affect glutathione peroxidase ac-
hypomethylation, evaluated by HpaII digestion and cy-tivity, thus altering the microenvironment in the propa-
tosine-extension assay in normal women. Disruption ofgation of ROS [14]. Endothelial glutathione peroxidase
nonrandom DNA methylation pattern can lead to inap-catalyzes the reduction of hydrogen and lipid peroxides
propriate gene expression and promotion of disease [17].to the corresponding alcohol, and it prevents the oxida-
In uremic patients, plasma levels of damaged proteins,tive inactivation of NO·. Homocysteine reduces mRNA
that is, proteins containing the L-isoaspartyl residues,levels of glutathione peroxidase, indicating that the ex-
are increased [18]. Folate treatment can lower, thoughpression of this enzyme protein is inhibited or down-
not significantly, levels of damaged plasma proteins,regulated.
meaning that other toxins besides homocysteine have a
Protein homocysteinylation/acylation role in protein damage [18].
Metabolic repercussions of folate administration, 15A post-biosynthetic acylation of free amino groups in
proteins is mediated by homocysteine thiolactone [15]. mg/day per os for two months, are to increase the eryth-
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